Search Results - "Arima, Junko"

Lovastatin inhibits bronchial hyperresponsiveness by reducing RhoA signaling in rat allergic asthma by Chiba, Yoshihiko, Arima, Junko, Sakai, Hiroyasu, Misawa, Miwa

“…Recent studies revealed an importance of a monomeric GTP-binding protein, RhoA, in contraction of bronchial smooth muscle (BSM). RhoA and its downstream have…”
Get more information

Nutritional Effect of Oral Supplement Enriched in ω-3 Fatty Acids, Arginine, RNA on Immune Response and Leukocyte-platelet Aggregate Formation in Patients Undergoing Cardiac Surgery by Iwase, Harunobu, Kariyazono, Hiroko, Arima, Junko, Yamamoto, Hiroyuki, Nakamura, Kazuo

“…The aim of the present study was to investigate the influence of a supplement enriched in ω-3 fatty acids on immune responses and platelet–leukocyte complex…”
Get full text

Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting by Nakamura, Kazuo, Masuda, Hiroshi, Kariyazono, Hiroko, Arima, Junko, Iguro, Yoshifumi, Yamada, Katsushi, Sakata, Ryuzo

“…This study was conducted to compare the effects of atorvastatin plus aspirin combined therapy on inflammatory responses, endothelial cell function, and blood…”
Get full text

MO29-1 The present activity and issues of AYA support team for the patients in AYA generation by Inagaki, Yuichiro, Negishi, Shuto, Sawa, Hitomi, Miyao, Kotaro, Takahashi, Kosuke, Arima, Junko, Sawa, Masashi

Get full text

P38-1 The clinical result of cancer multi-gene panel testing in Anjo Kosei Hospital by Inagaki, Yuichiro, Negishi, Syuto, Yokota, Hirofumi, Sawa, Hitomi, Miyao, Kotaro, Takahashi, Kosuke, Arima, Junko, Sawa, Masashi

Get full text

P25-9 The clinical courses of solid tumors with microsatellite instability-high (MSI-H) by Inagaki, Yuichiro, Ohara, Fumiya, Yokota, Hirofumi, Takeuchi, Yuki, Sawa, Hitomi, Miyao, Kotaro, Takashi, Seki, Arima, Junko, Yoneyama, Eiji, Sawa, Masashi

Get full text

Syringe‐dispensed omega‐3 lipid injectable emulsions should be stored under airtight refrigeration: A proposal for the efficient supply of unapproved precious lipid resources by Setoguchi, Makoto, Muto, Mitsuru, Ohata, Tomonori, Fukuoka, Ryuichi, Ikeda, Hirohito, Aki, Hatsumi, Haraguchi, Masaomi, Hanjo, Shota, Arima, Junko, Ibara, Satoshi

“…Background Both fish‐oil lipid injectable emulsion (FO‐ILE) and mixed‐oil lipid injectable emulsion (MO‐ILE) are key components of parenteral nutrition and…”
Get full text

The optimal treatment strategy in primary central nervous system lymphoma, 32 cases in our hospital by Takeuchi, Yuki, Inagaki, Yuichiro, Yokota, Hirofumi, Sawa, Hitomi, Taniyama, Shihomi, Imai, Kanae, Kato, Tomonori, Arima, Junko, Yoneyama, Eiji, Sawa, Masashi

Get full text

O2-13-2The optimal treatment strategy in primary central nervous system lymphoma, 32 cases in our hospital by Takeuchi, Yuki, Inagaki, Yuichiro, Yokota, Hirofumi, Sawa, Hitomi, Taniyama, Shihomi, Imai, Kanae, Kato, Tomonori, Arima, Junko, Yoneyama, Eiji, Sawa, Masashi

Get full text

The therapeutic effect and immune-related adverse event of nivolmab in Anjo Kosei Hospital by Inagaki, Yuichiro, Yokota, Hirofumi, Takeuchi, Yuki, Sawa, Hitomi, Seki, Takashi, Akita, Hidetoshi, Takeuchi, Mamiko, Mitsuya, Shoji, Arima, Junko, Yoneyama, Eiji, Sawa, Masashi

Get full text

P2-189The therapeutic effect and immune-related adverse event of nivolmab in Anjo Kosei Hospital by Inagaki, Yuichiro, Yokota, Hirofumi, Takeuchi, Yuki, Sawa, Hitomi, Seki, Takashi, Akita, Hidetoshi, Takeuchi, Mamiko, Mitsuya, Shoji, Arima, Junko, Yoneyama, Eiji, Sawa, Masashi

“…Abstract Background Nivolmab is approved as a novel immunocheckpoint inhibitor and peculiar immune-related adverse events (irAE) including interstitial lung…”
Get full text

The 10 years achievement of the ambulatory chemotherapy center in Anjo Kosei hospital by Inagaki, Yuichiro, Takeuchi, Yuki, Ohashi, Hitomi, Imai, Kanae, Kato, Tomonori, Seki, Takashi, Hiramatsu, Kiyoshi, Arima, Junko, Yoneyama, Eiji, Sawa, Masashi

Get full text

High-Trough Plasma Concentration of Afatinib Is Associated with Dose Reduction by Takahashi, Takayuki, Terazono, Hideyuki, Suetsugu, Takayuki, Sugawara, Hideki, Arima, Junko, Nitta, Mina, Tanabe, Toru, Okutsu, Kayu, Ikeda, Ryuji, Mizuno, Keiko, Inoue, Hiromasa, Takeda, Yasuo

“…Afatinib is used to treat non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutation as a second-generation EGFR-tyrosine…”
Get full text

Construction of the system of treatment for deep venous thrombosis with malignant tumor in Anjo Kosei Hospital by Inagaki, Yuichiro, Suzuki, Takahiro, Saeki, Satomi, Tsushita, Natsuko, Sakai, Toshiyasu, Kato, Tomonori, Manshio, Hiroyuki, Arima, Junko, Ono, Yoshitaka, Sawa, Masashi

Get full text

Nutritional Effect of Oral Supplement Enriched in ω-3 Fatty Acids, Arginine, RNA on Immune Response and Leukocyte–platelet Aggregate Formation in Patients Undergoing Cardiac Surgery by Harunobu Iwase, Hiroko Kariyazono, Junko Arima, Hiroyuki Yamamoto, Kazuo Nakamura

“…The aim of the present study was to investigate the influence of a supplement enriched in ω-3 fatty acids on immune responses and platelet–leukocyte complex…”
Get full text

Nutritional Effect of Oral Supplement Enriched in [omega]-3 Fatty Acids, Arginine, RNA on Immune Response and Leukocyte-platelet Aggregate Formation in Patients Undergoing Cardiac Surgery by Iwase, Harunobu, Kariyazono, Hiroko, Arima, Junko, Yamamoto, Hiroyuki, Nakamura, Kazuo

“…The aim of the present study was to investigate the influence of a supplement enriched in ω-3 fatty acids on immune responses and platelet-leukocyte complex…”
Get full text

Enhanced platelet responsiveness due to chilling and its relation to CD40 ligand level and platelet–leukocyte aggregate formation by Ayukawa, Osamu, Nakamura, Kazuo, Kariyazono, Hiroko, Ikeda, Ryuji, Arima, Junko, Shinkawa, Terutoshi, Iwase, Harunobu, Sakata, Ryuzo, Yamada, Katsushi

“…To investigate platelet responsiveness during cold storage of whole blood, we examined platelet aggregation, expression of CD40 ligand (CD40L) on platelets,…”
Get full text

Thymidine phosphorylase inhibits the expression of proapoptotic protein BNIP3 by Ikeda, Ryuji, Tajitsu, Yusuke, Iwashita, Ken-ichi, Che, Xiao-Fang, Yoshida, Kenichi, Ushiyama, Mina, Furukawa, Tatsuhiko, Komatsu, Masaharu, Yamaguchi, Tatsuya, Shibayama, Yoshihiko, Yamamoto, Masatatsu, Zhao, Hong-Ye, Arima, Junko, Takeda, Yasuo, Akiyama, Shin-ichi, Yamada, Katsushi

“…An angiogenic factor, thymidine phosphorylase (TP), confers resistance to apoptosis induced by hypoxia. We investigated the molecular basis for the suppressive…”
Get full text

Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood by Kariyazono, Hiroko, Nakamura, Kazuo, Arima, Junko, Ayukawa, Osamu, Onimaru, Shunji, Masuda, Hiroshi, Iguro, Yoshifumi, Majima, Hideyuki J, Sakata, Ryuzo, Yamada, Katsushi

“…To compare property in anti-platelet effects of aspirin (a cyclooxygenase inhibitor), cilostazol (a phosphodiesterase III inhibitor) and ramatroban (a specific…”
Get full text